Invention Grant
US08012477B2 Methods of treating multiple myeloma using IL-17 binding molecules
失效
使用IL-17结合分子治疗多发性骨髓瘤的方法
- Patent Title: Methods of treating multiple myeloma using IL-17 binding molecules
- Patent Title (中): 使用IL-17结合分子治疗多发性骨髓瘤的方法
-
Application No.: US12223050Application Date: 2007-01-30
-
Publication No.: US08012477B2Publication Date: 2011-09-06
- Inventor: Michael Cooreman , Franco E. Di Padova
- Applicant: Michael Cooreman , Franco E. Di Padova
- Applicant Address: CH Basel AT Vienna
- Assignee: Novartis AG,Novartis Pharma GmbH
- Current Assignee: Novartis AG,Novartis Pharma GmbH
- Current Assignee Address: CH Basel AT Vienna
- Agent Leslie Fischer
- International Application: PCT/US2007/061276 WO 20070130
- International Announcement: WO2007/117749 WO 20071018
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/395
Abstract:
An IL-17 binding molecule, in particular an antibody to human IL-17, more preferably a human antibody to human IL-17 is provided, wherein the hypervariable regions of the heavy and light chains have amino acid sequences as defined, for use in the treatment of a solid or hematological malignant diseases.
Public/Granted literature
- US20100266608A1 IL-17 Antagonistic Antibodies Public/Granted day:2010-10-21
Information query
